共 6 条
- [1] Anderson Mary E, 2018, JAAD Case Rep, V4, P1030, DOI 10.1016/j.jdcr.2018.08.014
- [4] Nordgaard-Lassen I, 2012, DAN MED J, V59
- [6] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors) [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 : S21 - S40